Nitric Oxide (NO) and NO Synthases (NOS)-Based Targeted Therapy for Colon Cancer

Cancers
Hao WangMeiyan Sun

Abstract

Colorectal cancer (CRC) is one of the most lethal malignancies worldwide and CRC therapy remains unsatisfactory. In recent decades, nitric oxide (NO)-a free-radical gas-plus its endogenous producer NO synthases (NOS), have attracted considerable attention. NO exerts dual effects (pro- and anti-tumor) in cancers. Endogenous levels of NO promote colon neoplasms, whereas exogenously sustained doses lead to cytotoxic functions. Importantly, NO has been implicated as an essential mediator in many signaling pathways in CRC, such as the Wnt/β-catenin and extracellular-signal-regulated kinase (ERK) pathways, which are closely associated with cancer initiation, metastasis, inflammation, and chemo-/radio-resistance. Therefore, NO/NOS have been proposed as promising targets in the regulation of CRC carcinogenesis. Clinically relevant NO-donating agents have been developed for CRC therapy to deliver a high level of NO to tumor sites. Notably, inducible NOS (iNOS) is ubiquitously over-expressed in inflammatory-associated colon cancer. The development of iNOS inhibitors contributes to targeted therapies for CRC with clinical benefits. In this review, we summarize the multifaceted mechanisms of NO-mediated networks in several hallmarks of CRC...Continue Reading

References

Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J S StamlerJ Loscalzo
Jan 1, 1987·Scandinavian Journal of Rheumatology. Supplement·J C Roujeau
Jun 1, 1988·Journal of Clinical Pharmacology·D C Brater
Jul 1, 1983·Clinical Pharmacokinetics·R K VerbeeckG R Loewen
Jan 1, 1980·Journal of Surgical Oncology·W R Waddell, R E Gerner
Sep 23, 1994·Cell·C Nathan, Q W Xie
Jun 1, 1993·Cancer Metastasis Reviews·M Belinsky, A K Jaiswal
Nov 1, 1996·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·A MukherjeeR Stein
Jun 1, 1996·Gastroenterology Clinics of North America·M J Thun
Feb 24, 1999·The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement·D J Ahnen
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·H MaedaK Hori
Mar 23, 2000·International Journal of Cancer. Journal International Du Cancer·L C JadeskiP K Lala
May 12, 2000·Critical Care Medicine·L LiaudetC Szabó
Jul 18, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·D M McCaffertyP Kubes
Nov 27, 2002·Cancer Investigation·Yaser RayyanBasil Rigas
Apr 3, 2003·Nature Reviews. Cancer·S Perwez HussainCurtis C Harris
Sep 19, 2003·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Andrzej S Tarnawski, Michael K Jones
Oct 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·Niharika NathBasil Rigas
Apr 23, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fabio CianchiEmanuela Masini
Jun 5, 2004·Proceedings of the National Academy of Sciences of the United States of America·Douglas D ThomasDavid A Wink
Jul 10, 2004·Trends in Molecular Medicine·Basil Rigas, Khosrow Kashfi
Oct 13, 2004·Mutation Research·Chinthalapally V Rao
Mar 5, 2005·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Liwei WangKeping Xie
Jul 19, 2005·Expert Opinion on Investigational Drugs·Roberto ScatenaBruno Giardina
Jul 27, 2005·Biochemical Society Transactions·K Kashfi, B Rigas
Sep 10, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jeff S IsenbergDavid D Roberts
Nov 12, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jianjun GaoBasil Rigas
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hiroyasu YasudaHidetada Sasaki
Apr 15, 2006·Inflammation & Allergy Drug Targets·Stefano Fiorucci, Elisabetta Antonelli
Apr 19, 2006·Cancer Research·Nengtai OuyangBasil Rigas
Jun 24, 2006·Nature Reviews. Cancer·Dai FukumuraRakesh K Jain
Jul 11, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Benjamin BonavidaHermes Garbán
Jul 11, 2006·The Journal of Biological Chemistry·Douglas D ThomasDavid A Wink
Nov 11, 2006·International Journal of Cancer. Journal International Du Cancer·Robyn L PrueittStefan Ambs

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.